Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions

Blood

Volumn 87, Issue 11, 1996, Pages 4862-4870

  Joneckis, Christopher C ^a   Shock, David D ^a   Cunningham, Michelle L ^a   Orringer, Eugene P ^a   Parise, Leslie V ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; COLLAGEN; DEXTRAN SULFATE; FIBRINOGEN; FIBRONECTIN; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; THROMBOSPONDIN; VITRONECTIN;

ARTICLE; BLOOD VESSEL OCCLUSION; CELL ADHESION; CELL DAMAGE; CELL SURFACE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEMOLYSIS; HUMAN; HUMAN CELL; IMMOBILIZED CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; SICKLE CELL ANEMIA;

EID: 0030008933     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.11.4862.bloodjournal87114862     Document Type: Article

References (60)

1. Hebble RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to vascular endothelial cells: Possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest 65:154, 1980
2. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR: Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325:11, 1991
3. Thomas AN, Pattison C, Serjeant GR: Causes of death in sickle-cell disease in Jamaica. Br Med J 285:633, 1982
4. Mohandas N, Evans E: Sickle erythrocyte adherence to vascular endothelium. J Clin Invest 76:1605, 1985
5. Hebbel RP, Boogearts MAB, Eaton JW, Steinberg MH: Erythrocyte adherence to the endothelium in sickle-cell anemia: A possible determinant of disease severity. N Engl J Med 302:992, 1980
6. Kaul DK, Fabry ME, Nagel RL: Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proc Natl Acad Sci USA 86:3356, 1989
7. Kaul DK, Fabry ME, Windisch P, Baez S, Nagel RL: Erythrocytes in sickle cell anemia are heterogenous in their rheological and hemodynamic characteristics. J Clin Invest 72:22, 1983
8. Mohandas N, Evans E: Adherence of sickle erythrocytes to vascular endothelial cells: Requirements for both cell membrane changes and plasma factors. Blood 64:282, 1984
9. Joneckis CC, Ackley RA, Orringer EP, Wayner EA, Parise LV: Integrin α4β1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 82:3548, 1993
10. + sickle reticulocytes to endothelial cells. Blood 80:2634, 1992
11. Swerlick RA, Eckman JR, Kumar A, Jeitler M, Wick TM: α4β1-integrin expression on sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 82:1891, 1993
12. Tandon NN, Kralisz U, Jamieson GA: Identification of GPIV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 264:7576, 1989
13. Asch AS, Liu I, Briccetti FM, Barnwell JW, Kwakye F, Dokun A, Goldberger J, Pernambuco M: Analysis of CD36 binding domains: Ligand specificity controlled by dephosphorylation of an ectodomain. Science 262:1436, 1993
14. Asch AS, Barnwell J, Silverstein RL, Nachman RL: Isolation of the thrombospondin membrane receptor. J Clin Invest 79:1054, 1987
15. Wayner EA, Kovach NL: Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin. J Cell Biol 116:489, 1992
16. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with leukocyte integrin VLA-4 at a site distinct from the VLA-4/ fibronectin binding site. Cell 60:577, 1990
17. Yabkowitz R, Dixit VM, Guo, N, Roberts DD, Shimizu: Activated T-cell adhesion to thrombospondin is mediated by the α4β1 (VLA-4) and α5β1 (VLA-5) integrins. J Immunol 151:149, 1993
18. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM: Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vasoocclusion. Blood 81:2137, 1993
19. Kumar A, Eckman JR, Swerlick RA, Wick TM: Sickle erythrocytes stimulated with phorbol ester adhere to endothelium via activated α4β1 integrin on sickle reticulocytes and fibronectin on endothelium. Blood 84:1616, 1994
20. Klug PP, Kay N, Jensen WN: Endothelial cell and vascular damage in the sickle cell disorder. Blood Cells 8:175, 1982
21. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr: Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 31:263, 1989
22. Mosher DF, Sottile J, Wu C, McDonald JA: Assembly of extracellular matrix. Curr Opin Cell Biol 4:810, 1992
23. Bini A, Fenoglio JJ, Mesa-Tejada R, Kudryk B, Kaplan KL: Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9:109, 1989
24. Parise LV, Phillips DR: Fibronectin-binding properties of the purified platelet glycoprotein IIb-IIIa complex. J Biol Chem 261:14011, 1986
25. Parise LV, Phillips DR: Reconstitution of the purified platelet fibrinogen receptor. J Biol Chem 260:10698, 1985
26. Lawler J, Derick LH, Connolly JE, Chen JH, Chao FC: The structure of human platelet thrombospondin. J Biol Chem 260:3762, 1985
27. Murphy-Ullrich JE, Mosher D: Localization of thrombospondin in clots formed in situ. Blood 65:1098, 1985
28. Caterson B, Christner JE, Baker JR, Couchman JR: Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc 44:386, 1985
29. Avnur Z, Geiger B: Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody. Cell 38:811, 1984
30. Sorette MP, Shiffer K, Clark MR: Improved isolation of normal human reticulocytes via exploitation of chloride-dependent potassium transport. Blood 80:249, 1992
31. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M: Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 70:152, 1987
32. Wick TM, Moake JL, Udden MM, Eskin SG, Sears DA, McIntire LV: Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest 80:905, 1987
33. Turitto VT: Blood viscosity, mass transport, and thrombogenesis. Prog Hemost Thromb 6:139, 1982
34. Grabowski EF: Sickle erythrocytes adhere to endothelial cell monolayers (ECM's) exposed to flowing blood, in Nagel RL (ed): Pathophysiological Aspects of Sickle Cell Vaso-occlusion. New York, NY, Liss, 1987, p 167
35. Sakariassen KS, Muggli R, Baumgartner HR: Measurements of platelet interaction with components of the vessel wall in flowing blood. Methods Enzymol 169:37, 1989
36. 2+-sensitive binding of thrombospondin to U937 cells is due to the formation of calcium precipitate in the binding medium. J Clin Invest 87:171, 1991
37. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301, 1994
38. Lawler J, Weinstein R, Hynes RO: Cell attachment to thrombospondin: The role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 107:2351, 1988
39. Asch AS, Silbiger S, Heimer E, Nachman RL: Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun 182:1208, 1992
40. Li W, Howard RJ, Leung LLK: Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor CD36. J Biol Chem 268:16179, 1993
41. Leung LLK, Li WX, McGregor JL, Albrecht G, Howard RJ: CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. J Biol Chem 267:18244, 1992
42. Dixit VM, Haverstrick DM, O'Rourke KM, Hennessy SW, Grant GA, Santoro SA, Frazier WA: A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc Natl Acad Sci USA 82:3472, 1985
43. Prater CA, Plotkin J, Jaye D, Frazier WA: The properdin-like type I repeats of human thrombospondin contain a cell attachment site. J Cell Biol 112:1031, 1991
44. Kosfeld MD, Pavlopoulos TV, Frazier WA: Cell attachment activity of the carboxyl-terminal domain of human thrombospondin. J Biol Chem 266:24257, 1991
45. Dixit VM, Galvin NJ, O'Rourke KM, Frazier WA: Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes. J Biol Chem 261:1962, 1986
46. Mosher DF, Sun X: Binding of thrombospondin to cell surface heparin sulfate proteoglycan, in Lahav J (ed): Thrombospondin, Boca Raton, FL, CRC, 1993, p 259
47. Fabry ME, Fine E, Rajanayagan V, Factor SM, Gore J, Sylla M, Nagel RL: Demonstration of endothelial adhesion of sickle cells in vivo: A distinct role for deformable sickle cell discocytes. Blood 79:1602, 1992
48. Patel VP, Giechanover A, Platt O, Lodish HF: Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes: Proc Natl Acad Sci USA 82:440, 1985
49. Rosemblatt M, Vuillet-Gaugler MH, Leroy C, Coulombel L: Coexpression of two fibronectin receptors, VLA-4 and VLA-5, by immature human erythroblastic precursor cells. J Clin Invest 87:6, 1991
50. Agbanyo FR, Sixma JJ, de Groot PG, Languino LR, Plow EF: Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest 92:288, 1993
51. Kojima N, Sadahira Y, Handa K, Hakomori S: Cell adhesion in a dynamic flow system as compared to static system. Glycosphingolipid-glycosphingolipid interaction in the dynamic system predominates over lectin or integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells. J Biol Chem 267: 17264, 1992
52. Brittain HA, Eckman JR, Wick TM: Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 120:538, 1992
53. Adams JC, Lawler J: Diverse mechanisms for cell attachment to platelet thrombospondin. J Cell Sci 104:1061, 1993
54. Asch AS, Tepler J, Silbiger S, Nachman RL: Cellular attachment to thromospondin: Cooperative interactions between receptor systems. J Biol Chem 266:1740, 1991
55. Parise LV, Steiner B, Nannizzi L, Criss AB, Phillips DR: Evidence for novel binding sites on the platelet glycoprotein IIb and IIIa subunits and immobilized fibrinogen. Biochem J 289:445, 1992
56. Zamarron C, Ginsberg MH, Plow EF: Monoclonal antibodies specific for a conformationally altered state of fibrinogen. Thromb Haemost 64:41, 1990
57. Ginsburg V, Roberts DD: Glycoconjugates and cell adhesion: The adhesive proteins laminin, thrombospondin and von Willebrand's factor bind specifically to sulfated glycolipids. Biochimie 70:1651, 1988
58. Roberts DD, Rao CN, Liotta LA, Gralnick HR, Ginsburg V: Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids. J Biol Chem 261:6872, 1986
59. Roberts DD: Sulfatide-binding proteins. Chem Phys Lipids 42:173, 1986
60. Hillery CA, Du M, Barbour TJ, Montgomery RR, Scott JP: An acidic lipid purified from sickle red blood cells specifically binds to thrombospondin. Blood 84:1609, 1994